---
title: "INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296357255.md"
description: "Fiscal 2026 saw 38% revenue growth to $4.2M, gross margin expansion to 48.63%, and a 22% increase in installed readers. Progress toward FDA clearance and U.S. market entry continued, with all clinical studies completed and submission on track for late 2026.Original document: Intelligent Bio Solutions Inc. [INBS] SEC 8-K Current Report — Aug. 19 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-19T12:36:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296357255.md)
  - [en](https://longbridge.com/en/news/296357255.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296357255.md)
generator: "portal-rs"
---

# INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026

Fiscal 2026 saw 38% revenue growth to $4.2M, gross margin expansion to 48.63%, and a 22% increase in installed readers. Progress toward FDA clearance and U.S. market entry continued, with all clinical studies completed and submission on track for late 2026.

Original document: Intelligent Bio Solutions Inc. \[INBS\] SEC 8-K Current Report — Aug. 19 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [INBS.US](https://longbridge.com/en/quote/INBS.US.md)

## Related News & Research

- [Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M](https://longbridge.com/en/news/296440057.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [LGMK: Revenue up 21% and gross margin at 70.2%; merger agreement to go private announced](https://longbridge.com/en/news/296383619.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**